UK investigates GlaxoSmithKline over "pay to delay" allegations

04/24/2013 | Ventura County Star (Calif.) (free registration)

The U.K. Office of Fair Trading is investigating allegations that GlaxoSmithKline has been paying competitors to delay market entry of their own versions of the GSK antidepressant Seroxat. If the watchdog agency decides that GSK was in violation, the drugmaker could be liable for fines of up to 30% of revenue during the period that the payments were made. "GSK supports fair competition and we very strongly believe that we acted within the law," the company said in a statement, vowing to cooperate fully in the investigation.

View Full Article in:

Ventura County Star (Calif.) (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY